$AHCO·8-K

AdaptHealth Corp. · May 5, 7:07 AM ET

Compare

AdaptHealth Corp. 8-K

Research Summary

AI-generated summary

Updated

AdaptHealth Corp. Reports Q1 2026 Results; COO Replaced

What Happened
AdaptHealth Corp. filed a Form 8-K on May 5, 2026 furnishing a press release (Exhibit 99.1) that announced the company’s financial results for the quarter ended March 31, 2026. Separately, on May 4, 2026 the company terminated Toby Scott Barnhart as Chief Operating Officer and appointed Daniel McFadden (previously Chief Business Systems Officer) as the new Chief Operating Officer.

Key Details

  • Press release dated May 5, 2026 reporting quarterly results for the period ended March 31, 2026 (furnished as Exhibit 99.1 to the 8-K).
  • Toby Scott Barnhart’s employment was terminated on May 4, 2026; he will receive severance and other benefits applicable to a termination without Cause under his employment agreement (see the company’s 2026 Proxy Statement filed April 28, 2026 for terms).
  • Daniel McFadden was appointed COO effective May 4, 2026; he was previously the company’s Chief Business Systems Officer.
  • The filing states Mr. McFadden has no family relationships with company officers or directors, no reportable related‑party transactions under Item 404(a) of Regulation S‑K, and no change to his compensation as of the filing.

Why It Matters
The 8-K confirms AdaptHealth has reported its quarterly financial results (investors should review Exhibit 99.1 for revenue, earnings, and other metrics). The immediate COO change may affect day‑to‑day operations and execution of operational initiatives; the filing notes contractual severance for the departing COO, the size of which is defined in the previously filed proxy. The appointment of an internal successor with no disclosed related‑party issues and no immediate compensation change suggests leadership continuity while investors assess the detailed quarterly results and any operational implications.

Loading document...